Saxenda is a medicine containing the active ingredient(s) liraglutide. On this page you will find out more about Saxenda, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: liraglutide
Information for medicine and pack size:
Saxenda 6 mg/mL injection solution, 3 x 3 mL injection devices
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
SAXENDA is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial Body Mass Index (BMI) of greater than or equal to 30 kg/m2 (obese) or greater than or equal to 27 kg/m2 to less than 30 kg/m2 (overweight) in the presence of at least one weight related comorbidity, such as dysglycaemia (pre-diabetes and type 2 diabetes mellitus), hypertension, dyslipidaemia, or obstructive sleep apnoea.,Treatment with SAXENDA should be discontinued after 12 weeks on the 3.0 mg/day dose if a patient has not lost at least 5% of their initial body weight.,Long term use should be informed by the following: Long term safety data are limited. Adverse reactions that are uncommon (frequency < 1/100) and/or are associated with prolonged use (>12 months) might not have been identified in the clinical development program [refer CLINICAL TRIALS]. Long term efficacy data are limited. The treatment effect has only been documented for 1 year [refer CLINICAL TRIALS].
Table of characteristics
|Visual appearance||Clear, colourless solution|
|Dosage Form||Injection, solution|
|Route of administration||Subcutaneous|
1 x 3mL Pre-filled pen - Fill volume - 3mL with an overfill to ensure an extractable amount of at least 3mL: Prescription Only Medicine, or Prescription Animal Remedy
3 x 3mL Pre-filled pen - Fill volume - 3mL with an overfill to ensure an extractable amount of at least 3mL: Prescription Only Medicine, or Prescription Animal Remedy
5 x 3mL Pre-filled pen - Fill volume - 3mL with an overfill to ensure an extractable amount of at least 3mL: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Protect from Light,Do not Freeze,Refrigerate|
|Life time||30 Months|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 1 results
Saxenda Solution for injection - myDr.com.au
Saxenda Solution for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 1 results
Transparency is good, independence from pharmaceutical industry is better! | Issue 4 | Volume 39 | Australian Prescriber
In Australia, the promotion of medicines to health professionals is controlled by self-regulatory schemes operated by the pharmaceutical industry.
Read more on Australian Prescriber website